葡萄糖皮质类药物在神经病学中的处方
Andrew P Jones1, Miguel Debono2, Jennifer Walsh3
1Neurology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Practical neurology
|March 29, 2024
概括
葡萄糖皮质类药物对神经系统疾病至关重要,但会带来诸如上腺功能衰竭等风险. 本指南提供了包括监测和检查清单在内的策略,以减轻皮质类固醇副作用,以确保更安全的患者护理.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经学 神经学
- 内分泌学 在内分泌学.
背景情况:
- 葡萄糖皮质类药物经常被用于治疗各种神经疾病.
- 它们的使用与显著的不良影响有关,影响多个器官系统.
研究的目的:
- 突出在神经系统疾病中使用皮质类固醇处方的潜在风险.
- 为减轻这些风险提供最新的多专业指导.
- 为了促进更安全的皮质类固醇处方实践.
主要方法:
- 审查当前关于皮质类固醇使用的文献和临床指南.
- 整合多专业专家的投入.
- 讨论风险减轻策略,包括监测和检查清单.
主要成果:
- 确定关键的不良影响:上腺功能不足,高血糖,骨质疏松症,感染风险.
- 强调需要对长期使用皮质类固醇的患者进行积极的风险管理.
- 引入实用工具,如家庭血糖监测和类固醇安全检查清单.
结论:
- 遵守最新的指南和实施安全措施对于最大限度地减少与皮质类固醇有关的危害至关重要.
- 多专业的合作有助于制定有效的风险减轻策略.
- 积极的监测和安全检查清单的使用可以显著改善用皮质类固醇治疗的神经疾病患者的结果.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
116
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
116
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
243
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
243
Hypoglycemia and Glucagon
257
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
257
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
162
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
162
Drug Dosage Regimen: Overview
3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K
Drug Delivery: Parenteral Route
515
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
515


